US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Potassium Chloride for Injection Concentrate USP

Reason Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.

B. Braun Medical Inc NDC 0264-1944-20 D-0370-2024
Class II · Moderate risk Terminated

Betimol

Reason Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.

Thea Pharma, Inc. NDC 82584-002-15 D-0374-2024
Class II · Moderate risk Ongoing

Febuxostat Tablets 80mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 16714-060-01 D-0369-2024
Class II · Moderate risk Ongoing

Febuxostat Tablets 40mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 16714-059-01 D-0368-2024
Class II · Moderate risk Completed

S.P Labs

Reason Failed Stability Specifications

Specialty Process Labs LLC D-0447-2024
Class II · Moderate risk Completed

S.P.Labs

Reason Failed Stability Specifications

Specialty Process Labs LLC NDC 81305-500-01 D-0446-2024
Class II · Moderate risk Ongoing

FentaNYL citrate

Reason Lack of Assurance of Sterility: Firm did not perform process validation.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0436-2024
Class II · Moderate risk Ongoing

Phenylephrine HCl

Reason Lack of Assurance of Sterility: Firm did not perform process validation.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0435-2024
Class II · Moderate risk Ongoing

hyalogic For Dry Eyes

Reason Lack of Assurance of Sterility

Optikem International, Inc. D-0384-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Red Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-158-15 D-0383-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Pink Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-013-15 D-0382-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Aging Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-027-15 D-0381-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Floaters Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-098-15 D-0380-2024
Class II · Moderate risk Ongoing

TRP Eye strain Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-172-15 D-0379-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Dryness Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-178-15 D-0378-2024
Class II · Moderate risk Ongoing

TRP Eye Twitching Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-040-15 D-0377-2024
Class II · Moderate risk Ongoing

TRP Blur Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-002-11 D-0376-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Allergy Eyes Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-032-15 D-0375-2024
Class II · Moderate risk Terminated

Tobramycin for Injection

Reason Failed Stability Specification: Water determination was found not complying with specification.

Eugia US LLC NDC 55150-470-06 D-0385-2024
Class II · Moderate risk Ongoing

Nicardipine Hydrochloride Injection

Reason Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Eugia US LLC NDC 55150-183-11 D-0391-2024
Class II · Moderate risk Ongoing

Nicardipine Hydrochloride Injection

Reason Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Eugia US LLC NDC 55150-183-10 D-0390-2024
Class II · Moderate risk Ongoing

Lidocaine HCL 1%

Reason Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Denver Solutions, LLC DBA Leiters Health NDC 71449-090-42 D-0363-2024
Class II · Moderate risk Ongoing

Moxifloxacin 5mg/ml

Reason Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Denver Solutions, LLC DBA Leiters Health NDC 71449-097-42 D-0362-2024
Class II · Moderate risk Ongoing

Moxifloxacin PF

Reason Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Denver Solutions, LLC DBA Leiters Health NDC 71449-096-42 D-0361-2024